Strategic partnership to advance monoclonal antibody discovery
Icosagen, a contract research, development, and manufacturing organisation (CRDMO) specialising in innovative antibody research and production, has announced a strategic partnership with Lead Discovery Center GmbH (LDC), a translational drug discovery organisation. The collaboration aims to discover monoclonal antibody portfolios targeting therapeutically relevant proteins, including a pivotal G-protein coupled receptor (GPCR), which are often challenging […]